LH · 10-Q · 2026Q3 · Full report

Revenue Performance and Mix

LABCORP HOLDINGS INC. · 2026-10-30 · Importance 43 · Surprise 32 · From source text

For the three months ended September 30, 2026, revenue was $3,810.0 million, up 6.9% year over year; nine-month revenue was $11,078.7 million, up 6.2%. Third-quarter growth included 5.5% organic revenue growth and a 1.5% contribution from acquisitions, net of divestitures, partly offset by 0.1% unfavorable foreign currency translation. Third-quarter Dx revenue increased 6.5% to $2,948.9 million, with requisition volume up 4.8% and price/mix up 1.7%; BLS revenue increased 8.5% to $866.7 million, primarily on 9.6% organic growth. For the first nine months, Dx revenue rose 5.7% to $8,611.7 million and BLS revenue rose 7.7% to $2,483.5 million.

Key facts

• For the three months ended September 30, 2026, Labcorp revenues were $3,810.0 million, up 6.9% from $3,563.5 million in 2025; growth comprised 5.5% organic revenue and 1.5% acquisitions net of divestitures, offset by 0.1% unfavorable currency translation. source
• For the nine months ended September 30, 2026, Labcorp revenues were $11,078.7 million, up 6.2% from $10,435.9 million in 2025; growth included 4.3% organic revenue, 1.3% acquisitions net of divestitures, and 0.5% favorable currency translation. source

Impact estimates